| human | Q5 |
| P227 | GND ID | 173102816 |
| P2671 | Google Knowledge Graph ID | /g/11dylxs0zq |
| P269 | IdRef ID | 083800123 |
| P213 | ISNI | 0000000043635373 |
| P244 | Library of Congress authority ID | n90657798 |
| P8189 | National Library of Israel J9U ID | 987007443813205171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 173964796 |
| P691 | NL CR AUT ID | mub2014834271 |
| P856 | official website | https://www.medschool.umaryland.edu/profiles/Levine-Myron/ |
| P214 | VIAF ID | 37071439 |
| P10832 | WorldCat Entities ID | E39PBJm9c6GQmMyQWCFFrjhJXd |
| P166 | award received | Maxwell Finland Award | Q6796097 |
| P27 | country of citizenship | United States of America | Q30 |
| P69 | educated at | Albert Einstein College of Medicine | Q2030894 |
| City College of New York | Q1093910 | ||
| London School of Hygiene & Tropical Medicine | Q1126189 | ||
| VCU Medical Center | Q7906647 | ||
| University of Maryland School of Medicine | Q17681492 | ||
| P108 | employer | University of Maryland | Q503415 |
| P734 | family name | Levine | Q21510733 |
| Levine | Q21510733 | ||
| Levine | Q21510733 | ||
| P735 | given name | Myron | Q18607970 |
| Myron | Q18607970 | ||
| P106 | occupation | university teacher | Q1622272 |
| P21 | sex or gender | male | Q6581097 |
| Q38001080 | "IDEAL" vaccines for resource poor settings |
| Q24289279 | A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA |
| Q59307572 | A Recombinant Live Oral Cholera Vaccine |
| Q33818020 | A Research Agenda to Underpin Malaria Eradication |
| Q37028664 | A case for immunization against nosocomial infections |
| Q33676706 | A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). |
| Q39464862 | A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults |
| Q35737846 | A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety |
| Q33557714 | A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors |
| Q34204703 | A rabbit model of non-typhoidal Salmonella bacteremia. |
| Q41986831 | A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccin |
| Q42915324 | A scalable method for biochemical purification of Salmonella flagellin |
| Q46339112 | A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali |
| Q36412063 | A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries |
| Q35637207 | Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model |
| Q37623663 | Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. |
| Q38184714 | Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies |
| Q39373037 | Aeromonas-Associated Diarrhea in Children Under 5 Years: The GEMS Experience |
| Q43630851 | Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007. |
| Q37483766 | Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR |
| Q37696581 | An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution |
| Q35047221 | Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors |
| Q38645960 | Animal-related factors associated with moderate-to-severe diarrhea in children younger than five years in western Kenya: A matched case-control study |
| Q52602663 | Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. |
| Q35065640 | Assessment of the epidemiology and burden of measles in Southern Mozambique |
| Q30278777 | Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children |
| Q30411937 | Association between moderate-to-severe diarrhea in young children in the global enteric multicenter study (GEMS) and types of handwashing materials used by caretakers in Mirzapur, Bangladesh |
| Q34976024 | Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats |
| Q34441769 | Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa |
| Q30299938 | Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies |
| Q34345075 | Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study |
| Q40507046 | Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine |
| Q36854777 | CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression |
| Q44723286 | Can Giardia lamblia infection lower the risk of acute diarrhea among preschool children? |
| Q78754511 | Can needle-free administration of vaccines become the norm in global immunization? |
| Q41582033 | Case/control studies with follow-up: Constructing the source population to estimate effects of risk factors on development, disease, and survival |
| Q34070619 | Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines |
| Q35729793 | Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. |
| Q37739063 | Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells |
| Q37562339 | Chaperone-Usher Pili Loci of Colonization Factor-Negative Human Enterotoxigenic Escherichia coli |
| Q40577517 | Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2. |
| Q30299919 | Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates |
| Q38776163 | Characterization of a multicomponent live, attenuated Shigella flexneri vaccine |
| Q33908929 | Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins |
| Q37276296 | Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes |
| Q39949206 | Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q56342019 | Clinical, environmental, and behavioral characteristics associated with Cryptosporidium infection among children with moderate-to-severe diarrhea in rural western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS) |
| Q59127826 | Coli Surface Antigen 26 Acts as an Adherence Determinant of Enterotoxigenic and Is Cross-Recognized by Anti-CS20 Antibodies |
| Q61806436 | Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS) |
| Q30301296 | Community based case-control study of rotavirus gastroenteritis among young children during 2008-2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata |
| Q50057317 | Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. |
| Q40565111 | Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. |
| Q42361179 | Corrigendum: In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages |
| Q40538305 | Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a |
| Q37350955 | Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates |
| Q30578108 | Data management and other logistical challenges for the GEMS: the data coordinating center perspective |
| Q39146446 | Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. |
| Q30279261 | Design, recruitment, and microbiological considerations in human challenge studies. |
| Q37108048 | Determinants of health care seeking for diarrheal illness in young children in urban slums of Kolkata, India |
| Q36412073 | Determinants of household costs associated with childhood diarrhea in 3 South Asian settings |
| Q82728298 | Developing the next generation of vaccinologists |
| Q33579987 | Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa |
| Q30423347 | Diagnostic microbiologic methods in the GEMS-1 case/control study |
| Q30412052 | Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition |
| Q35606839 | Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0-59 Months Seeking Care at Health Facilities |
| Q42561946 | Diarrheal disease constitutes one of the top two causes of mortality among young children in developing countries. Preface |
| Q45072369 | Direct Detection of Shigella in Stool Specimens by Use of a Metagenomic Approach |
| Q44737011 | Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children |
| Q37305395 | Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings |
| Q38284901 | Distribution of classical and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from Chilean children and tRNA gene screening for putative insertion sites for genomic islands |
| Q37458618 | Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release |
| Q34488529 | Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial |
| Q28051937 | Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) |
| Q38879736 | Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial |
| Q46793235 | Efficacy of the oral pentavalent rotavirus vaccine in Mali |
| Q35273267 | Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains |
| Q35949699 | Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy |
| Q36444089 | Enteric infections and the vaccines to counter them: future directions |
| Q30443288 | Enteric infections, diarrhea, and their impact on function and development |
| Q40435116 | Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique |
| Q30276185 | Epidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS) |
| Q49953578 | Erratum: Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings |
| Q94479686 | Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27subclone |
| Q41367176 | Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements |
| Q33712039 | Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model |
| Q30276039 | Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants |
| Q36412068 | Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings |
| Q33183819 | Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL |
| Q40118345 | Factors Associated with the Duration of Moderate-to-Severe Diarrhea among Children in Rural Western Kenya Enrolled in the Global Enteric Multicenter Study, 2008-2012. |
| Q41581938 | Factors that explain excretion of enteric pathogens by persons without diarrhea |
| Q35964671 | Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella |
| Q34716080 | Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain |
| Q44366021 | Genomic analysis of human rotavirus strains G6P[14] and G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events |
| Q30428800 | Genomic characterization of enteroaggregative Escherichia coli from children in Mali |
| Q30276038 | Genomic diversity of EPEC associated with clinical presentations of differing severity |
| Q36184367 | Glycoconjugate vaccine strategies for protection against invasive Salmonella infections |
| Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
| Q47701344 | Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. |
| Q37108012 | Health Care Utilization and Attitudes Survey: understanding diarrheal disease in rural Gambia |
| Q37108025 | Health care seeking for childhood diarrhea in developing countries: evidence from seven sites in Africa and Asia |
| Q37108043 | Health care use patterns for diarrhea in children in low-income periurban communities of Karachi, Pakistan |
| Q37108039 | Health care utilization and attitudes survey in cases of moderate-to-severe diarrhea among children ages 0-59 months in the District of Manhica, southern Mozambique |
| Q37108020 | Health care-seeking behavior during childhood diarrheal illness: results of health care utilization and attitudes surveys of caretakers in western Kenya, 2007-2010 |
| Q37108052 | Health care-seeking behavior for childhood diarrhea in Mirzapur, rural Bangladesh |
| Q37696600 | Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. |
| Q30457238 | High genotypic diversity among rotavirus strains infecting Gambian children |
| Q30418588 | Housefly population density correlates with shigellosis among children in Mirzapur, Bangladesh: a time series analysis |
| Q64081813 | Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS) |
| Q40190831 | How the current West African Ebola virus disease epidemic is altering views on the need for vaccines and is galvanizing a global effort to field-test leading candidate vaccines |
| Q57173696 | Human microbial challenge: the ultimate animal model |
| Q33541011 | Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali |
| Q41913004 | Identification of Coli Surface Antigen 23, a novel adhesin of enterotoxigenic Escherichia coli |
| Q40095911 | Identification of immune correlates of protection in Shigella infection by application of machine learning |
| Q64449454 | Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains |
| Q91338642 | Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba |
| Q40530217 | Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide |
| Q35943000 | Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia |
| Q64943704 | Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation. |
| Q21245322 | Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine |
| Q46307485 | Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model |
| Q73816644 | Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies |
| Q37476100 | Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants |
| Q36253755 | Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans |
| Q37675513 | Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model |
| Q59806094 | Improving Our Understanding of Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain |
| Q36324812 | In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. |
| Q36601934 | In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines |
| Q41426133 | Insights from natural infection-derived immunity to cholera instruct vaccine efforts |
| Q30421768 | Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa |
| Q46517735 | Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhiça, a rural area of southern Mozambique |
| Q36133462 | Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine Development |
| Q40378524 | Invasive non-typhoidal Salmonella in Mozambican children |
| Q45754072 | Invasive nontyphoidal Salmonella disease in Africa: current status |
| Q39689520 | Invasive pneumococcal infections among hospitalized children in Bamako, Mali |
| Q43940958 | Invasive salmonella infections and HIV in Northern Tanzania |
| Q36412054 | Laboratory diagnostic challenges in case/control studies of diarrhea in developing countries |
| Q52719380 | Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. |
| Q35598035 | Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit |
| Q27003066 | Live attenuated vaccines for invasive Salmonella infections |
| Q37643333 | Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B |
| Q36017715 | Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans |
| Q40468569 | Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age. |
| Q34526276 | Management of typhoid fever in children |
| Q59132934 | Manipulation of Typhi Gene Expression Impacts Innate Cell Responses in the Human Intestinal Mucosa |
| Q61453230 | Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali |
| Q37176794 | Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial |
| Q62486723 | Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk |
| Q80186096 | Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys |
| Q30408229 | Microbiota that affect risk for shigellosis in children in low-income countries |
| Q38821062 | Microgravity as a biological tool to examine host-pathogen interactions and to guide development of therapeutics and preventatives that target pathogenic bacteria |
| Q36275289 | Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa |
| Q57927103 | Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 |
| Q59307549 | Morphological studies on fimbriae expressed by Vibrio cholerae 01 |
| Q37880344 | Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge |
| Q41941037 | Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine. |
| Q28387065 | Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine |
| Q36444097 | Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers |
| Q33360323 | Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coli |
| Q36005810 | Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali |
| Q40290632 | Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies |
| Q40734790 | Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines |
| Q36051755 | Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease |
| Q35660952 | Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease |
| Q34562262 | Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans |
| Q34784851 | Overview of vaccines and immunisation |
| Q36672996 | PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella Isolates from the blood of patients with clinical enteric fever |
| Q51150718 | PaxVax CVD 103-HgR single-dose live oral cholera vaccine. |
| Q34120926 | Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults |
| Q55260950 | Pneumonia mortality and healthcare utilization in young children in rural Bangladesh: a prospective verbal autopsy study. |
| Q39637935 | Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile |
| Q45394779 | Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen |
| Q37233946 | Predictors of diarrheal mortality and patterns of caregiver health seeking behavior in in Karachi, Pakistan |
| Q40468538 | Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile. |
| Q40500946 | Prevention of typhoid fever |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q46472877 | Properties of haemolysin E (HlyE) from a pathogenic Escherichia coli avian isolate and studies of HlyE export |
| Q37089561 | Quality of piped and stored water in households with children under five years of age enrolled in the Mali site of the Global Enteric Multi-Center Study (GEMS). |
| Q30416070 | Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries |
| Q30424736 | Real-time PCR-based mismatch amplification mutation assay for specific detection of CS6-expressing allelic variants of enterotoxigenic Escherichia coli and its application in assessing diarrheal cases and asymptomatic controls |
| Q50097465 | Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy |
| Q36281257 | Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice |
| Q112341167 | Relationship Between IgG Seroprevalence and the Immune Response to Poliovirus Vaccine Among School-Age Children From a Population With Near-Universal Immunity Level. |
| Q93214448 | Reviving the “Moore Swab”: a Classic Environmental Surveillance Tool Involving Filtration of Flowing Surface Water and Sewage Water to Recover Typhoidal Salmonella Bacteria |
| Q64112196 | Risk factors for death among children 0-59 months of age with moderate-to-severe diarrhea in Manhiça district, southern Mozambique |
| Q81445405 | Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media |
| Q40160745 | Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study |
| Q37544964 | Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks. |
| Q59245323 | Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children |
| Q42264370 | Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates |
| Q43536234 | Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector |
| Q36634226 | Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans |
| Q37430026 | Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis |
| Q37106127 | Salmonella enterica serovar Typhi live vector vaccines finally come of age |
| Q35272921 | Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis |
| Q30276876 | Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007-2011: Case-Control Study |
| Q39511350 | Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa |
| Q30543267 | Seeking care for pediatric diarrheal illness from traditional healers in Bamako, Mali |
| Q37067246 | Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative |
| Q62487673 | Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique |
| Q33601858 | Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines |
| Q30418380 | Setting priorities for development of emerging interventions against childhood diarrhoea |
| Q30419255 | Setting research priorities to reduce mortality and morbidity of childhood diarrhoeal disease in the next 15 years |
| Q36920244 | Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. |
| Q34202171 | Shigella isolates from the global enteric multicenter study inform vaccine development |
| Q37110690 | Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity |
| Q41965778 | Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections |
| Q36915108 | Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor. |
| Q30423340 | Some epidemiologic, clinical, microbiologic, and organizational assumptions that influenced the design and performance of the Global Enteric Multicenter Study (GEMS). |
| Q44130886 | Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants |
| Q36412081 | Statistical methods in the Global Enteric Multicenter Study (GEMS). |
| Q35934056 | Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey. |
| Q38648228 | Summary of workshop "global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques". |
| Q44782691 | Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, chile. |
| Q30414062 | Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection |
| Q34760675 | Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates. |
| Q52657631 | T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. |
| Q30276745 | The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS) |
| Q51783346 | The Gathering Storm: Is Untreatable Typhoid Fever on the Way? |
| Q36412034 | The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study |
| Q30423344 | The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis |
| Q37563642 | The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae |
| Q30352868 | The Relationship Between Distance to Water Source and Moderate-to-Severe Diarrhea in the Global Enterics Multi-Center Study in Kenya, 2008-2011 |
| Q57275157 | The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, |
| Q35826028 | The causes of hospital admission and death among children in Bamako, Mali |
| Q64114155 | The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicent |
| Q58144447 | The role of HIV infection in the etiology and epidemiology of diarrheal disease among children aged 0-59 months in Manhiça District, Rural Mozambique |
| Q26700366 | The role of research in viral disease eradication and elimination programs: lessons for malaria eradication |
| Q59307590 | The significance of Vibrio cholerae in the United States |
| Q28307137 | Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B |
| Q57934710 | Typhoid Fever: Way Forward |
| Q34844912 | Typhoid fever in Fiji: a reversible plague? |
| Q56888190 | Typhoid fever in Santiago, Chile: Insights from a mathematical model utilizing venerable archived data from a successful disease control program |
| Q50054015 | Typhoid vaccines ready for implementation |
| Q33873628 | Ultra-fast and sensitive detection of non-typhoidal Salmonella using microwave-accelerated metal-enhanced fluorescence ("MAMEF"). |
| Q81521467 | University of Maryland, Baltimore's participation in global health |
| Q34500955 | Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub |
| Q36898558 | Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors |
| Q30275836 | Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study |
| Q40544482 | Use of vaccines for the prevention of typhoid fever. |
| Q36105906 | Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a |
| Q40582738 | Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci |
| Q80020558 | Vaccine development strategies for improving immunization: the role of modern immunology |
| Q37421298 | Vaccines, global health and social equity |
| Q59355070 | Water, Sanitation, and Hygiene Characteristics among HIV-Positive Households Participating in the Global Enteric Multicenter Study in Rural Western Kenya, 2008-2012 |
| Q56340269 | What is the best immunization strategy for protecting African children against invasive Salmonella disease? |
| Myron M. Levine | wikipedia |
Search more.